

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 7.72116265 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 7.72116265 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.72116265 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.72116265 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.72116265 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 7.72116265 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 7.55945337 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.93326049 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.73087758 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.67698730 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 5.60090438 |
| 12 | regulation of interferon-alpha production (GO:0032647) | 5.32981342 |
| 13 | microglial cell activation (GO:0001774) | 5.25956745 |
| 14 | response to host immune response (GO:0052572) | 5.01870649 |
| 15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.01870649 |
| 16 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.78613811 |
| 17 | B cell receptor signaling pathway (GO:0050853) | 4.65439235 |
| 18 | response to host (GO:0075136) | 4.61498329 |
| 19 | response to host defenses (GO:0052200) | 4.61498329 |
| 20 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.61498329 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.53204600 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.47448787 |
| 23 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.44169995 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 4.37493175 |
| 25 | detection of other organism (GO:0098543) | 4.33759197 |
| 26 | I-kappaB phosphorylation (GO:0007252) | 4.30948970 |
| 27 | detection of bacterium (GO:0016045) | 4.16060026 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 4.07148467 |
| 29 | macrophage activation (GO:0042116) | 4.04647010 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.98723700 |
| 31 | positive regulation of antigen processing and presentation (GO:0002579) | 3.96830844 |
| 32 | positive regulation of interferon-beta production (GO:0032728) | 3.96605479 |
| 33 | response to peptidoglycan (GO:0032494) | 3.90988613 |
| 34 | respiratory burst (GO:0045730) | 3.87448359 |
| 35 | myeloid cell activation involved in immune response (GO:0002275) | 3.84816689 |
| 36 | germinal center formation (GO:0002467) | 3.79924272 |
| 37 | negative regulation of cell killing (GO:0031342) | 3.78700698 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.78700698 |
| 39 | regulation of B cell differentiation (GO:0045577) | 3.76632838 |
| 40 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.76031015 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.75850301 |
| 42 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.75164975 |
| 43 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.58436169 |
| 44 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.58436169 |
| 45 | pinocytosis (GO:0006907) | 3.56700519 |
| 46 | positive thymic T cell selection (GO:0045059) | 3.56258366 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.54853878 |
| 48 | neutrophil activation (GO:0042119) | 3.52974529 |
| 49 | B cell homeostasis (GO:0001782) | 3.50849563 |
| 50 | granulocyte activation (GO:0036230) | 3.49928318 |
| 51 | cytidine metabolic process (GO:0046087) | 3.44135727 |
| 52 | cytidine catabolic process (GO:0006216) | 3.44135727 |
| 53 | cytidine deamination (GO:0009972) | 3.44135727 |
| 54 | mature B cell differentiation (GO:0002335) | 3.41885607 |
| 55 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.41355691 |
| 56 | natural killer cell mediated immunity (GO:0002228) | 3.41355691 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.41064029 |
| 58 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.33753259 |
| 59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.30270354 |
| 60 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.28234705 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 3.28099412 |
| 62 | negative regulation of B cell proliferation (GO:0030889) | 3.27265998 |
| 63 | detection of biotic stimulus (GO:0009595) | 3.26969878 |
| 64 | cellular extravasation (GO:0045123) | 3.24258953 |
| 65 | T-helper 1 type immune response (GO:0042088) | 3.23246927 |
| 66 | response to muramyl dipeptide (GO:0032495) | 3.22049950 |
| 67 | regulation of mast cell degranulation (GO:0043304) | 3.21576617 |
| 68 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.21346414 |
| 69 | neutrophil mediated immunity (GO:0002446) | 3.19713606 |
| 70 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.18508641 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.16857041 |
| 72 | positive regulation of leukocyte degranulation (GO:0043302) | 3.16246159 |
| 73 | defense response to protozoan (GO:0042832) | 3.16160172 |
| 74 | regulation of mast cell activation (GO:0033003) | 3.13604685 |
| 75 | B cell mediated immunity (GO:0019724) | 3.12592044 |
| 76 | response to protozoan (GO:0001562) | 3.10623507 |
| 77 | negative thymic T cell selection (GO:0045060) | 3.09262345 |
| 78 | negative regulation of granulocyte differentiation (GO:0030853) | 3.09233227 |
| 79 | leukocyte aggregation (GO:0070486) | 3.07827523 |
| 80 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.07662205 |
| 81 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.07023139 |
| 82 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06642283 |
| 83 | NIK/NF-kappaB signaling (GO:0038061) | 3.06347826 |
| 84 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.06093436 |
| 85 | regulation of interferon-beta production (GO:0032648) | 3.05382804 |
| 86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04969498 |
| 87 | response to type I interferon (GO:0034340) | 3.03946449 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03927538 |
| 89 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03118250 |
| 90 | negative regulation of mast cell activation (GO:0033004) | 3.02981274 |
| 91 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.02781094 |
| 92 | type I interferon signaling pathway (GO:0060337) | 3.01812001 |
| 93 | cellular response to type I interferon (GO:0071357) | 3.01812001 |
| 94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00216710 |
| 95 | cellular response to interferon-gamma (GO:0071346) | 2.99309622 |
| 96 | T cell migration (GO:0072678) | 2.96962780 |
| 97 | positive regulation of type 2 immune response (GO:0002830) | 2.96698504 |
| 98 | positive regulation of mast cell activation (GO:0033005) | 2.96019330 |
| 99 | N-acetylneuraminate metabolic process (GO:0006054) | 2.95743452 |
| 100 | myeloid leukocyte activation (GO:0002274) | 2.95521620 |
| 101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93862553 |
| 102 | regulation of gamma-delta T cell activation (GO:0046643) | 2.93091102 |
| 103 | positive T cell selection (GO:0043368) | 2.92581408 |
| 104 | negative T cell selection (GO:0043383) | 2.92288854 |
| 105 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.89756691 |
| 106 | negative regulation of interleukin-6 production (GO:0032715) | 2.89587542 |
| 107 | T cell selection (GO:0045058) | 2.88813215 |
| 108 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87854943 |
| 109 | histamine secretion (GO:0001821) | 2.86545068 |
| 110 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.84406636 |
| 111 | negative regulation of interleukin-17 production (GO:0032700) | 2.84278250 |
| 112 | regulation of mononuclear cell migration (GO:0071675) | 2.83282978 |
| 113 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83185402 |
| 114 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.82961614 |
| 115 | negative regulation of interleukin-12 production (GO:0032695) | 2.82721899 |
| 116 | regulation of B cell proliferation (GO:0030888) | 2.82458716 |
| 117 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.81598573 |
| 118 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.81141579 |
| 119 | regulation of T cell tolerance induction (GO:0002664) | 2.79276346 |
| 120 | interferon-gamma production (GO:0032609) | 2.78085514 |
| 121 | positive regulation of interleukin-12 production (GO:0032735) | 2.77943502 |
| 122 | tolerance induction (GO:0002507) | 2.76923949 |
| 123 | cellular response to exogenous dsRNA (GO:0071360) | 2.73830816 |
| 124 | * B cell proliferation (GO:0042100) | 2.73707930 |
| 125 | cellular response to interferon-beta (GO:0035458) | 2.72926482 |
| 126 | regulation of germinal center formation (GO:0002634) | 2.72775455 |
| 127 | myeloid dendritic cell activation (GO:0001773) | 2.72209315 |
| 128 | regulation of leukocyte degranulation (GO:0043300) | 2.71470164 |
| 129 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.70548203 |
| 130 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69064997 |
| 131 | cellular response to zinc ion (GO:0071294) | 2.67743112 |
| 132 | positive regulation of chemokine production (GO:0032722) | 2.67637992 |
| 133 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.67274606 |
| 134 | positive regulation of mast cell degranulation (GO:0043306) | 2.67274606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.69601796 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.54671093 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.84041677 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.38962880 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.33586257 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.93826959 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.87784909 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.79040948 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.64907799 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.33745866 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.28926797 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.25936024 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.08519894 |
| 14 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.05979954 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.89641860 |
| 16 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.72848579 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.66788416 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.63330289 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.41692847 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40894682 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.39243877 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.38409434 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27338570 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.27122187 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.24048270 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20772463 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15798257 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 2.14025689 |
| 29 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.12470750 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.05655277 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05038923 |
| 32 | * MYB_26560356_Chip-Seq_TH2_Human | 1.99961813 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98954256 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97954613 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96128923 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.94674762 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.93595425 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.93576251 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.91780850 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.85472151 |
| 41 | * MAF_26560356_Chip-Seq_TH1_Human | 1.85006264 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72428496 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72194392 |
| 44 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.69698819 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65225659 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62135451 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55882103 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54467042 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51209822 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49005895 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46342424 |
| 52 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35968435 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34628992 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34326029 |
| 55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34074958 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31441127 |
| 57 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29262982 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.28746502 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28398809 |
| 60 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26553978 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22834714 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20701122 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18274263 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16681246 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15891738 |
| 66 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15192837 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14808970 |
| 68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13796317 |
| 69 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12762765 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11736422 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08342804 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06331336 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06301258 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06105538 |
| 75 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05285449 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04367704 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04150464 |
| 78 | MAF_26560356_Chip-Seq_TH2_Human | 1.03336346 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02801759 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95533046 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95373383 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94450100 |
| 83 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.92614427 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92274000 |
| 85 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88716491 |
| 86 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86485741 |
| 87 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83569636 |
| 88 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82817558 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81922375 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 0.81436154 |
| 91 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.79788875 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77651699 |
| 93 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76745427 |
| 94 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.76633527 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75366987 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74563731 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.74072402 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73731003 |
| 99 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73231647 |
| 100 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.73000162 |
| 101 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.72715778 |
| 102 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72238868 |
| 103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.71348438 |
| 104 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71270126 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71007827 |
| 106 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.70998622 |
| 107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.70401722 |
| 108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69643490 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66339743 |
| 110 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.63489468 |
| 111 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.61173017 |
| 112 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.60166052 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59542246 |
| 114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.58470771 |
| 115 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.58139463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.58182795 |
| 2 | MP0003303_peritoneal_inflammation | 3.85739554 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.58964330 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.25956021 |
| 5 | MP0001790_abnormal_immune_system | 3.23820678 |
| 6 | MP0005387_immune_system_phenotype | 3.23820678 |
| 7 | MP0006082_CNS_inflammation | 3.23026019 |
| 8 | MP0003172_abnormal_lysosome_physiology | 3.21491408 |
| 9 | * MP0001800_abnormal_humoral_immune | 3.21264583 |
| 10 | MP0003436_decreased_susceptibility_to | 3.07828162 |
| 11 | * MP0002452_abnormal_antigen_presenting | 3.00315950 |
| 12 | MP0002419_abnormal_innate_immunity | 2.93255268 |
| 13 | * MP0005000_abnormal_immune_tolerance | 2.91096221 |
| 14 | MP0005671_abnormal_response_to | 2.73357267 |
| 15 | * MP0002723_abnormal_immune_serum | 2.62363599 |
| 16 | MP0000685_abnormal_immune_system | 2.61815608 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.47598280 |
| 18 | MP0005025_abnormal_response_to | 2.43836376 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.40891519 |
| 20 | * MP0001819_abnormal_immune_cell | 2.40828751 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.40503146 |
| 22 | MP0004510_myositis | 2.24955629 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.20668809 |
| 24 | MP0009785_altered_susceptibility_to | 2.19567323 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.04813381 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.96321118 |
| 27 | * MP0002398_abnormal_bone_marrow | 1.93638026 |
| 28 | * MP0000716_abnormal_immune_system | 1.91698303 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.86891465 |
| 30 | * MP0000689_abnormal_spleen_morphology | 1.85968018 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.85332915 |
| 32 | MP0001853_heart_inflammation | 1.85303911 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.84317637 |
| 34 | MP0002405_respiratory_system_inflammati | 1.79127329 |
| 35 | MP0004947_skin_inflammation | 1.74201910 |
| 36 | * MP0001845_abnormal_inflammatory_respons | 1.70174775 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.68564172 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.67036631 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.60375005 |
| 40 | MP0003690_abnormal_glial_cell | 1.57615303 |
| 41 | * MP0002429_abnormal_blood_cell | 1.56502578 |
| 42 | MP0005310_abnormal_salivary_gland | 1.55963869 |
| 43 | * MP0002722_abnormal_immune_system | 1.54282963 |
| 44 | MP0009840_abnormal_foam_cell | 1.50566210 |
| 45 | MP0009278_abnormal_bone_marrow | 1.49611026 |
| 46 | MP0010307_abnormal_tumor_latency | 1.47275324 |
| 47 | MP0000604_amyloidosis | 1.43468463 |
| 48 | MP0008469_abnormal_protein_level | 1.42679581 |
| 49 | MP0003724_increased_susceptibility_to | 1.37293385 |
| 50 | MP0003448_altered_tumor_morphology | 1.34254640 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.34131997 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.32233528 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.30300882 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.29990346 |
| 55 | MP0001873_stomach_inflammation | 1.29003764 |
| 56 | MP0001851_eye_inflammation | 1.27918224 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.25544909 |
| 58 | MP0005451_abnormal_body_composition | 1.21256284 |
| 59 | MP0002006_tumorigenesis | 1.20985089 |
| 60 | MP0003075_altered_response_to | 1.20446121 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.19087175 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.15074327 |
| 63 | MP0000343_altered_response_to | 1.14958892 |
| 64 | MP0002933_joint_inflammation | 1.12786239 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.12317056 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.12317056 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.10317741 |
| 68 | MP0005166_decreased_susceptibility_to | 1.09533310 |
| 69 | MP0003828_pulmonary_edema | 1.05661969 |
| 70 | MP0009764_decreased_sensitivity_to | 1.01121576 |
| 71 | MP0004883_abnormal_blood_vessel | 1.00773445 |
| 72 | MP0003763_abnormal_thymus_physiology | 0.99390139 |
| 73 | MP0000703_abnormal_thymus_morphology | 0.98331521 |
| 74 | MP0000371_diluted_coat_color | 0.97588388 |
| 75 | MP0000858_altered_metastatic_potential | 0.90711909 |
| 76 | MP0002139_abnormal_hepatobiliary_system | 0.89178076 |
| 77 | MP0008004_abnormal_stomach_pH | 0.87008434 |
| 78 | MP0002132_abnormal_respiratory_system | 0.83877683 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.83515388 |
| 80 | MP0003091_abnormal_cell_migration | 0.82358917 |
| 81 | MP0000490_abnormal_crypts_of | 0.78152736 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.77303557 |
| 83 | MP0003045_fibrosis | 0.76390851 |
| 84 | MP0000767_abnormal_smooth_muscle | 0.76188679 |
| 85 | MP0002277_abnormal_respiratory_mucosa | 0.75274439 |
| 86 | MP0002928_abnormal_bile_duct | 0.72912306 |
| 87 | MP0010352_gastrointestinal_tract_polyps | 0.71997872 |
| 88 | MP0009763_increased_sensitivity_to | 0.71897315 |
| 89 | MP0005390_skeleton_phenotype | 0.71078065 |
| 90 | MP0004381_abnormal_hair_follicle | 0.71015362 |
| 91 | MP0001915_intracranial_hemorrhage | 0.70107872 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 0.68879119 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.68501472 |
| 94 | * MP0002136_abnormal_kidney_physiology | 0.66788578 |
| 95 | MP0002090_abnormal_vision | 0.66173306 |
| 96 | * MP0000249_abnormal_blood_vessel | 0.66114769 |
| 97 | MP0003866_abnormal_defecation | 0.63621995 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 0.62924962 |
| 99 | MP0005197_abnormal_uvea_morphology | 0.61021802 |
| 100 | MP0003795_abnormal_bone_structure | 0.60107842 |
| 101 | MP0002254_reproductive_system_inflammat | 0.59771434 |
| 102 | MP0008874_decreased_physiological_sensi | 0.59571450 |
| 103 | MP0003646_muscle_fatigue | 0.57626523 |
| 104 | MP0002095_abnormal_skin_pigmentation | 0.56850366 |
| 105 | MP0005164_abnormal_response_to | 0.56584082 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.56102879 |
| 107 | MP0003252_abnormal_bile_duct | 0.55619835 |
| 108 | MP0008260_abnormal_autophagy | 0.55214686 |
| 109 | MP0001958_emphysema | 0.54976982 |
| 110 | MP0005023_abnormal_wound_healing | 0.54938966 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54894672 |
| 112 | MP0009115_abnormal_fat_cell | 0.54513001 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.54152062 |
| 114 | MP0002009_preneoplasia | 0.53374745 |
| 115 | MP0006054_spinal_hemorrhage | 0.53321074 |
| 116 | MP0000920_abnormal_myelination | 0.52708590 |
| 117 | MP0000609_abnormal_liver_physiology | 0.52142742 |
| 118 | MP0001663_abnormal_digestive_system | 0.51506335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.19754199 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.68075985 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 5.40330641 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.81647588 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.80094832 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.50627592 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.41766663 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.29110873 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.29110873 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.29110873 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.23090157 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.05567620 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.91256925 |
| 14 | Disinhibition (HP:0000734) | 3.85189757 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.72527135 |
| 16 | Recurrent skin infections (HP:0001581) | 3.72106515 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 3.68618217 |
| 18 | Cellulitis (HP:0100658) | 3.64876058 |
| 19 | Recurrent viral infections (HP:0004429) | 3.62162154 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.47640585 |
| 21 | Colitis (HP:0002583) | 3.46821217 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.46178786 |
| 23 | Vasculitis (HP:0002633) | 3.37903981 |
| 24 | Agammaglobulinemia (HP:0004432) | 3.36766023 |
| 25 | Obstructive lung disease (HP:0006536) | 3.33942327 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.33942327 |
| 27 | Mucopolysacchariduria (HP:0008155) | 3.31492284 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.31492284 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.29686409 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.29686409 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.29686409 |
| 32 | Glomerulonephritis (HP:0000099) | 3.28005899 |
| 33 | Encephalitis (HP:0002383) | 3.19432121 |
| 34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.13058904 |
| 35 | Inflammation of the large intestine (HP:0002037) | 3.05780526 |
| 36 | Agnosia (HP:0010524) | 3.04122517 |
| 37 | Myositis (HP:0100614) | 3.03480341 |
| 38 | Recurrent pneumonia (HP:0006532) | 3.00351017 |
| 39 | Axonal loss (HP:0003447) | 2.97314507 |
| 40 | IgM deficiency (HP:0002850) | 2.97211701 |
| 41 | Gingivitis (HP:0000230) | 2.94404127 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.94255653 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.94255653 |
| 44 | Meningitis (HP:0001287) | 2.93393485 |
| 45 | Hemoptysis (HP:0002105) | 2.92656082 |
| 46 | Osteomyelitis (HP:0002754) | 2.90956095 |
| 47 | Loss of speech (HP:0002371) | 2.88654943 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.87149551 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.85621172 |
| 50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.81765916 |
| 51 | Chronic otitis media (HP:0000389) | 2.78762252 |
| 52 | Emphysema (HP:0002097) | 2.77778734 |
| 53 | Myocardial infarction (HP:0001658) | 2.74794882 |
| 54 | Recurrent lower respiratory tract infections (HP:0002783) | 2.73913790 |
| 55 | T lymphocytopenia (HP:0005403) | 2.73025255 |
| 56 | Hematochezia (HP:0002573) | 2.71934284 |
| 57 | Periodontitis (HP:0000704) | 2.71370059 |
| 58 | Chest pain (HP:0100749) | 2.63683029 |
| 59 | Prostate neoplasm (HP:0100787) | 2.63681719 |
| 60 | Abnormality of T cell number (HP:0011839) | 2.61570958 |
| 61 | Lymphopenia (HP:0001888) | 2.59007463 |
| 62 | Petechiae (HP:0000967) | 2.58599598 |
| 63 | Basal ganglia calcification (HP:0002135) | 2.55981851 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.55585522 |
| 65 | Prolonged bleeding time (HP:0003010) | 2.52553148 |
| 66 | Epistaxis (HP:0000421) | 2.50121763 |
| 67 | Recurrent bronchitis (HP:0002837) | 2.47661779 |
| 68 | Increased IgE level (HP:0003212) | 2.47634590 |
| 69 | Keratoconjunctivitis (HP:0001096) | 2.46500746 |
| 70 | Interstitial pulmonary disease (HP:0006530) | 2.45709961 |
| 71 | Restrictive lung disease (HP:0002091) | 2.45405003 |
| 72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44784144 |
| 73 | Orchitis (HP:0100796) | 2.43968177 |
| 74 | Pustule (HP:0200039) | 2.43448395 |
| 75 | Abnormality of T cells (HP:0002843) | 2.42109222 |
| 76 | Purpura (HP:0000979) | 2.41188245 |
| 77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.37776347 |
| 78 | Stomatitis (HP:0010280) | 2.37368166 |
| 79 | Recurrent sinusitis (HP:0011108) | 2.35660927 |
| 80 | Pulmonary embolism (HP:0002204) | 2.35200065 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.32777151 |
| 82 | Pathologic fracture (HP:0002756) | 2.30641043 |
| 83 | IgA deficiency (HP:0002720) | 2.29096971 |
| 84 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25856070 |
| 85 | Optic neuritis (HP:0100653) | 2.22606003 |
| 86 | Retrobulbar optic neuritis (HP:0100654) | 2.22606003 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.19478930 |
| 88 | Thoracic kyphosis (HP:0002942) | 2.17744338 |
| 89 | Abnormality of the pleura (HP:0002103) | 2.17266978 |
| 90 | Thyroiditis (HP:0100646) | 2.16568224 |
| 91 | Pulmonary infiltrates (HP:0002113) | 2.15640208 |
| 92 | Spontaneous hematomas (HP:0007420) | 2.15548111 |
| 93 | Abnormality of T cell physiology (HP:0011840) | 2.14890953 |
| 94 | Upper motor neuron abnormality (HP:0002127) | 2.14796228 |
| 95 | Inappropriate behavior (HP:0000719) | 2.14550487 |
| 96 | Chronic diarrhea (HP:0002028) | 2.13562158 |
| 97 | Cerebral aneurysm (HP:0004944) | 2.12239058 |
| 98 | Leukopenia (HP:0001882) | 2.09706324 |
| 99 | Polyneuropathy (HP:0001271) | 2.09596963 |
| 100 | Gingival bleeding (HP:0000225) | 2.09553405 |
| 101 | Leukocytosis (HP:0001974) | 2.08675656 |
| 102 | Panhypogammaglobulinemia (HP:0003139) | 2.07438863 |
| 103 | Retinal atrophy (HP:0001105) | 2.05876564 |
| 104 | Verrucae (HP:0200043) | 2.04715438 |
| 105 | Papilloma (HP:0012740) | 2.04715438 |
| 106 | Abnormal platelet function (HP:0011869) | 2.04361230 |
| 107 | Impaired platelet aggregation (HP:0003540) | 2.04361230 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 2.03955488 |
| 109 | J-shaped sella turcica (HP:0002680) | 2.03183096 |
| 110 | Urethral obstruction (HP:0000796) | 1.98444243 |
| 111 | IgG deficiency (HP:0004315) | 1.98094668 |
| 112 | Eosinophilia (HP:0001880) | 1.97178552 |
| 113 | Increased IgM level (HP:0003496) | 1.96699314 |
| 114 | Anorexia (HP:0002039) | 1.96673973 |
| 115 | Nephritis (HP:0000123) | 1.96311998 |
| 116 | Sepsis (HP:0100806) | 1.96134237 |
| 117 | Amyloidosis (HP:0011034) | 1.96110064 |
| 118 | Viral hepatitis (HP:0006562) | 1.95949703 |
| 119 | Thick nail (HP:0001805) | 1.95841614 |
| 120 | Arterial thrombosis (HP:0004420) | 1.95426339 |
| 121 | Complement deficiency (HP:0004431) | 1.95221361 |
| 122 | Urticaria (HP:0001025) | 1.95132289 |
| 123 | Mutism (HP:0002300) | 1.94139299 |
| 124 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93217857 |
| 125 | Arthralgia (HP:0002829) | 1.91465800 |
| 126 | Skin rash (HP:0000988) | 1.90939421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.51094217 |
| 2 | RIPK4 | 3.40438962 |
| 3 | TGFBR2 | 3.32054531 |
| 4 | KIT | 3.24818364 |
| 5 | CSF1R | 2.90851341 |
| 6 | BLK | 2.90405908 |
| 7 | TYK2 | 2.88487626 |
| 8 | ERN1 | 2.85535071 |
| 9 | IRAK4 | 2.64340693 |
| 10 | IRAK3 | 2.59428297 |
| 11 | TBK1 | 2.59154039 |
| 12 | MAP3K14 | 2.40565994 |
| 13 | CAMK1D | 2.21245613 |
| 14 | SYK | 2.13898236 |
| 15 | JAK1 | 2.01126045 |
| 16 | SIK2 | 1.91959708 |
| 17 | MAP3K13 | 1.88575323 |
| 18 | CAMK1G | 1.85214539 |
| 19 | BTK | 1.79174048 |
| 20 | HCK | 1.78464893 |
| 21 | TAOK3 | 1.71667461 |
| 22 | STK10 | 1.71375697 |
| 23 | CDK12 | 1.68461202 |
| 24 | ZAP70 | 1.63089787 |
| 25 | FES | 1.62431517 |
| 26 | IKBKE | 1.61966107 |
| 27 | IKBKB | 1.59057689 |
| 28 | BMPR2 | 1.55638489 |
| 29 | JAK3 | 1.54977705 |
| 30 | LYN | 1.54137123 |
| 31 | ITK | 1.51149065 |
| 32 | CSK | 1.46863340 |
| 33 | PRPF4B | 1.41872367 |
| 34 | NEK9 | 1.31529553 |
| 35 | LCK | 1.28218066 |
| 36 | GRK7 | 1.23555868 |
| 37 | CLK1 | 1.23353828 |
| 38 | MARK3 | 1.20212284 |
| 39 | TEC | 1.19151955 |
| 40 | MATK | 1.16937604 |
| 41 | FRK | 1.16429095 |
| 42 | MAP3K11 | 1.14481116 |
| 43 | PIK3CG | 1.14458898 |
| 44 | MAP2K3 | 1.12159884 |
| 45 | TXK | 1.11385985 |
| 46 | ACVR1B | 1.10143235 |
| 47 | GRK6 | 1.08149352 |
| 48 | SIK3 | 1.05721865 |
| 49 | FGR | 1.04487078 |
| 50 | RPS6KA4 | 0.99255390 |
| 51 | TAOK1 | 0.97950786 |
| 52 | LRRK2 | 0.94780051 |
| 53 | CDK19 | 0.94269808 |
| 54 | EPHB1 | 0.91617635 |
| 55 | CDC42BPA | 0.90315427 |
| 56 | CHUK | 0.89854828 |
| 57 | FGFR3 | 0.86860219 |
| 58 | JAK2 | 0.82873953 |
| 59 | MAP3K1 | 0.81802601 |
| 60 | MAP3K10 | 0.81218559 |
| 61 | EGFR | 0.78728221 |
| 62 | IRAK1 | 0.75090548 |
| 63 | CDK6 | 0.74212560 |
| 64 | PIM1 | 0.73733350 |
| 65 | PKN2 | 0.69099002 |
| 66 | ABL1 | 0.65925050 |
| 67 | PRKCQ | 0.65216725 |
| 68 | SCYL2 | 0.62206924 |
| 69 | STK4 | 0.61159833 |
| 70 | MAPK12 | 0.60886273 |
| 71 | PTK6 | 0.59302405 |
| 72 | PDK1 | 0.58094930 |
| 73 | TTN | 0.57832575 |
| 74 | BRD4 | 0.57758814 |
| 75 | PRKCH | 0.54925935 |
| 76 | MAPK7 | 0.54122417 |
| 77 | MARK2 | 0.53496153 |
| 78 | STK3 | 0.51690121 |
| 79 | PRKCD | 0.50581557 |
| 80 | PTK2B | 0.50347906 |
| 81 | MAP3K9 | 0.48236008 |
| 82 | MAP2K6 | 0.48085853 |
| 83 | CAMKK2 | 0.46374451 |
| 84 | IRAK2 | 0.45859809 |
| 85 | FYN | 0.44758605 |
| 86 | PDPK1 | 0.41716705 |
| 87 | MAPKAPK2 | 0.41584780 |
| 88 | TAOK2 | 0.40932844 |
| 89 | TRIB3 | 0.40427814 |
| 90 | PAK4 | 0.40284604 |
| 91 | TESK2 | 0.38654030 |
| 92 | YES1 | 0.37704916 |
| 93 | ALK | 0.37343469 |
| 94 | NLK | 0.36624905 |
| 95 | FGFR4 | 0.36149673 |
| 96 | NME2 | 0.34759050 |
| 97 | SGK3 | 0.34206655 |
| 98 | INSRR | 0.34201124 |
| 99 | MAP2K2 | 0.33922467 |
| 100 | BMX | 0.33751846 |
| 101 | TRPM7 | 0.33643329 |
| 102 | CAMKK1 | 0.33376653 |
| 103 | PRKD2 | 0.33219963 |
| 104 | IGF1R | 0.32549165 |
| 105 | HIPK2 | 0.32238220 |
| 106 | STK11 | 0.32150627 |
| 107 | KSR2 | 0.31625542 |
| 108 | DAPK2 | 0.30515013 |
| 109 | MAPK4 | 0.30290124 |
| 110 | MOS | 0.29816455 |
| 111 | MAPK11 | 0.29429025 |
| 112 | CAMK4 | 0.29159306 |
| 113 | ATR | 0.29016353 |
| 114 | CDK4 | 0.28252446 |
| 115 | INSR | 0.28245391 |
| 116 | MAP3K8 | 0.28017470 |
| 117 | RPS6KL1 | 0.27034241 |
| 118 | RPS6KC1 | 0.27034241 |
| 119 | RPS6KA6 | 0.26687260 |
| 120 | ADRBK2 | 0.26386451 |
| 121 | MAP3K5 | 0.26194242 |
| 122 | CDK9 | 0.26135636 |
| 123 | OXSR1 | 0.25931399 |
| 124 | SIK1 | 0.24597186 |
| 125 | TNK2 | 0.23814454 |
| 126 | GRK1 | 0.23455292 |
| 127 | DMPK | 0.23024675 |
| 128 | SRC | 0.21508664 |
| 129 | MAP3K3 | 0.20935723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.46480368 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.36413840 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.23784019 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.01930581 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89957916 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.88945636 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.82564534 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.65919930 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.59500929 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.44597476 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.39849159 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.25050917 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.18161001 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.06584407 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.96345315 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.93585916 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.91626439 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.88567515 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.87361036 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.67329360 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.65002499 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63909388 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61982651 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60068344 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57659713 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56412834 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50186916 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.47635349 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.44634307 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.44317307 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40184504 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39393237 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37695863 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35117397 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34968975 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.33306812 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.31178116 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25337107 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.25075391 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20888072 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.18897990 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16609268 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14146526 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.11281637 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07719087 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06744312 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.00062515 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 0.99022605 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.95114678 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94990104 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94524753 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93373720 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92758180 |
| 54 | Allograft rejection_Homo sapiens_hsa05330 | 0.90645448 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89606756 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88243416 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87478699 |
| 58 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87263997 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85527248 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85338319 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85318564 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84652868 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.83555906 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.82061092 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77959635 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73677599 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71690716 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70802237 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69619247 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.67030647 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64732494 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64094311 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58678649 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58361748 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57807107 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.56622107 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56552365 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56056928 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55234701 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54862932 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54409340 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52376709 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52217843 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51940012 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51924530 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49551687 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48803583 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48565767 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42789211 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42017925 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.41149191 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40363616 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39488425 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.36242886 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35370590 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34888610 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34811856 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33253675 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.32964668 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32375330 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.31547932 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.29319296 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.26625107 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26065829 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25381899 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.23579843 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22814416 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21834695 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21805207 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20943448 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19547064 |
| 112 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18991078 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18369743 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.18160473 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15915361 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.15700889 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11200674 |

